Company intelligence / Profile preview

Epocrates

Watertown, Massachusetts, United States

Ownership: Private
Employees: ~54
Development stage: Commercial

Overview

Epocrates delivers digital clinical decision support to over one million U.S. clinicians through its mobile and web platforms. The app provides drug interaction checkers, diagnostic tools, guidelines, calculators, local infection data ("Bugs + Drugs"), and continuing medical education content. It maintains a high user retention rate (>90%) among core users[7][1][5]. No clinical trial results are relevant as this is not a therapeutics company.

Modalities: Non-pharmacological therapy (digital clinical decision support platform)
Industry: Digital Health Medical Devices

Partnerships

Relode (healthcare hiring partnership)Cognito Therapeutics (video messaging to HCPs partnership)Multiple pharmaceutical companies and medical education providers for CME content hosting

Beyond the preview

Go deeper on Epocrates.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epocrates.

Explore the full profile